Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma therapy for treatment of patients with COVID-19
IRCT20210714051887N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Sep 2020
- Countries
- 1
01
Overview
Phase 3 trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Started Sep 2020; status: completed.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20210714051887N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210714051887N1.